HK Stock Market Move | KNOWLEDGE ATLAS (02513) rises by more than 4%, the company is rushing for A-share IPO. Flagship model GLM4.7 shows outstanding performance in programming scenarios.

09:50 27/01/2026

Wisdom Power (02513) rose by more than 4%, as of the time of publication, it has increased by 4.61% to 227 HK dollars, with a trading volume of 70.6198 million HK dollars.

KNOWLEDGE ATLAS (02513) up by over 4%, at the time of publication, up by 4.61%, at 227 Hong Kong dollars, with a turnover of 70.6198 million Hong Kong dollars. On the news front, recently, the official website of the China Securities Regulatory Commission updated information showing that CICC submitted the third phase IPO guidance progress report for KNOWLEDGE ATLAS on January 15. KNOWLEDGE ATLAS is currently continuing its A-share listing plan and moving towards the "A+H" dual listing goal. Previously, the company released the flagship model GLM-4.7 of KNOWLEDGE ATLAS. Soochow believes that the GLM series iterates rapidly, with GLM4.7 showing outstanding performance in programming scenarios, adopting an interweaving thinking mechanism and strong stability in real software engineering tasks. AutoGLM realizes AI autonomous operation for smartphones and computer GUI, opening up a new paradigm for agents. Multimodal capabilities cover areas such as text-image, text-video, and visual understanding, with CogView-4 and CogVideoX ranking high in open source evaluations.

NIKE, Inc. Class B (NKE.US) has launched a new round of automation transformation, laying off 775 people at its distribution center in the United States in order to "streamline" the supply chain.

HK Stock Market Move | CSTONE PHARMA-B(02616) rose more than 4%, executive director Yang Jianxin once again increased holdings, accumulating nearly 12.48 million shares purchased.

HK Stock Market Move | KEYMED BIO-B(02162) increased by nearly 3%, its self-developed BCMACD3 bispecific antibody CM336 was granted FTD designation by the FDA.

NIKE, Inc. Class B (NKE.US) has launched a new round of automation transformation, laying off 775 people at its distribution center in the United States in order to "streamline" the supply chain.

HK Stock Market Move | CSTONE PHARMA-B(02616) rose more than 4%, executive director Yang Jianxin once again increased holdings, accumulating nearly 12.48 million shares purchased.

HK Stock Market Move | KEYMED BIO-B(02162) increased by nearly 3%, its self-developed BCMACD3 bispecific antibody CM336 was granted FTD designation by the FDA.